Table 2.
Characteristics of control group and patient group.
| Control group (n = 288) | HCMP (n = 102) | DCMP (n = 55) | Old MI (n = 201) | ||
|---|---|---|---|---|---|
| Age (yr) | 49.8 ± 16.3 | 59.4 ± 12.9 | 59.8 ± 13.3 | 65.8 ± 10.5 | |
| BSA | 1.7 ± 0.2 | 1.8 ± 0.2 | 1.7 ± 0.3 | 1.8 ± 0.2 | |
| ST mode | LVEF (%) | 67.7 ± 6.8 | 71.2 ± 10.0 | 32.9 ± 7.1 | 53.6 ± 13.5 |
| LVEDVI (mL/m2) | 72.8 ± 11.0 | 74.9 ± 15.9 | 139.2 ± 35.2 | 95.3 ± 28.1 | |
| LVESVI (mL/2) | 23.8 ± 7.2 | 22.1 ± 11.7 | 94.4 ± 30.9 | 46.7 ± 26.2 | |
| LVMI (g/m2) | 54.8 ± 7.2 | 97.1 ± 28.8 | 101.1 ± 27.0 | 69.9 ± 16.7 | |
| BV mode | LVEF (%) | 73.2 ± 4.9 | 70.9 ± 10.6 | 38.7 ± 8.8 | 56.4 ± 12.7 |
| LVEDVI (mL/m2) | 64.2 ± 10.9 | 58.0 ± 13.3 | 118.1 ± 30.4 | 80.6 ± 24.5 | |
| LVESVI (mL/2) | 17.3 ± 4.6 | 17.1 ± 9.2 | 73.8 ± 27.6 | 37.2 ± 21.7 | |
| LVMI (g/m2) | 68.8 ± 9.8 | 121.0 ± 33.0 | 131.1 ± 32.7 | 91.2 ± 22.0 | |
| Diff | LVEF (%) | 5.5 ± 4.1 | −0.3 ± 3.8 | 5.7 ± 4.1 | 2.8 ± 4.2 |
| LVEDVI (mL/m2) | −8.6 ± 3.9 | −16.8 ± 6.3 | −21.1 ± 8.7 | −14.7 ± 7.4 | |
| LVESVI (mL/m2) | −6.5 ± 3.3 | −5.0 ± 3.3 | −20.6 ± 6.3 | −9.6 ± 6.0 | |
| LVMI (g/m2) | 14.1 ± 4.1 | 23.9 ± 7.7 | 30.1 ± 9.5 | 21.3 ± 7.3 | |
| % PM to LVEDV | 11.9 ± 5.6 | 22.7 ± 7.1 | 15.0 ± 5.0 | 15.4 ± 5.8 | |
| % PM to LVM | 20.2 ± 4.3 | 20.0 ± 4.7 | 23.0 ± 5.4 | 23.2 ± 4.3 | |
BSA = body surface area, LVEF = left ventricular ejection fraction, LVEDVI = LV end-diastolic volume index, LVESVI = LV end-systolic volume index, LVMI = LV mass index, PM = papillary muscle and trabeculae, LVM = LV mass.